London, United Kingdom,– DNA Electronics Ltd. a developer of semiconductor solutions for real-time DNA and RNA detection, today announces that it has licensed its ground-breaking Genalysis® technology platform for rapid, lab-free DNA detection to geneOnyx, a company that is delivering on-the-spot genetic analytics services for cosmetics and skincare applications. Following a successful evaluation of the […]
SAN DIEGO– Illumina, Inc., a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function, announced today that it filed definitive proxy materials with the Securities and Exchange Commission (SEC) in connection with its 2012 Annual Meeting of Stockholders, to be held on April 18, […]
Austin, TX,– Bioo Scientific’s updated NEXTflex™ ChIP-Seq Kit now includes an optional protocol to completely eliminate gel size selection. The alternative bead-based protocol reduces the required sample prep time by 2 hours and allows for complete automation of library prep. According to Dr. Masoud Toloue, Director of Genomic Research at Bioo Scientific, “gel size selection […]
Genomics software company Biomatters, the creators of Geneious, have appointed former Managing Director Dr. Brett Ammundsen as CEO, to lead the company as genomics extends from research into new clinical and consumer applications. With a background career in science and with peer-reviewed publications and patents to his name, Brett spent the last decade utilizing his […]
SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced that Erasmus Medical Center, Rotterdam, Netherlands, has selected the Agilent SureSelect XT Human All Exon target enrichment system along with the Agilent Bravo automated liquid-handling platform as part of the Erasmus Rucphen Family study to identify genetic risk factors for some complex genetic disorders. The […]
SAN DIEGO– Illumina (NASDAQ:ILMN) today introduced the TruSeq Amplicon – Cancer Panel, a highly multiplexed panel that will allow researchers to accurately sequence hundreds of the most relevant cancer loci, even in difficult samples such as formalin-fixed, paraffin embedded (FFPE) tumor samples. With the ability to detect mutations below 5% frequency, the TruSeq Amplicon assay […]
GREENVILLE, S.C. – The new Lab21 Clinical Genomics Center at ITOR will allow cancer patients in the Upstate to be among the first in the region to benefit from new technology that will allow patients to get real-time feedback and treatment plans tied to their cancer’s specific DNA signature. “Bringing this leading-edge technology to the […]
Cambridge, UK – Lab21 Limited, the global specialist in personalized medicine and clinical diagnostics, today announces the launch of a new Clinical Genomics Center located within the Greenville Hospital System (GHS) Memorial Medical Campus in Greenville, South Carolina. The center will be physically located within the GHS Institute for Translational Oncology Research (ITOR) as part […]
La Jolla, CA RNA sequencing is rapidly becoming a routine tool for many researchers. The data from RNA-Seq experiments is more expansive and detailed than from other technologies for transcriptome analysis, including microarrays. However, the optimal analysis of RNA-Seq datasets presents bioinformatics challenges for general users. The Voila! cloud-based data analysis service offered by Prognosys […]
LARCHMONT, N.Y.–LadaTech LLC, which is jointly owned by GlaxoSmithKline (GSK) and IP Finance Holdings, announced today that a jury has found that Illumina Inc. (ILMN) has infringed a patent owned by LadaTech covering essential aspects of the Solexa DNA sequencing technology in a major patent infringement lawsuit in Delaware. (LadaTech, LLC v. Illumina, Inc. and […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
